PAHC stock forecast
Our latest prediction for Phibro Animal Health Corp.'s stock price was made on the Sept. 12, 2018 when the stock price was at 44.80$.
In the short term (2weeks), PAHC's stock price should outperform the market by 0.23%. During that period the price should oscillate between -4.61% and +4.96%.
In the medium term (3months), PAHC's stock price should outperform the market by 0.41%. During that period the price should oscillate between -10.93% and +13.54%.Get email alerts
About Phibro Animal Health Corp.
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
At the moment the company generates 827M USD in revenues.
On its last earning announcement, the company reported a profit of 1.61$ per share.
The book value per share is 4.58$
Three months stock forecastSept. 12, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|